Pam Gabris

Vice President of Development Strategy and Study Management for Drug Development
Sector:
CRO
Location:
Madison, WI

About Labcorp:  Labcorp is a global Diagnostics and Drug Development life sciences and healthcare company harnessing science for human good. Every day, our mission is to improve health and improve lives. Our world-class diagnostic tests help enable and accelerate a patient's care and access to innovative treatments, medicines and new technologies that can change outcomes and lives. We generate more safety and efficacy data to support drug approvals than any other company. And we help patients of all backgrounds find and participate in trials that can improve their health—broadening access to information, choices and advancements in science to our global population. From test results that give healthcare providers insights on individual patient care, to the ability to recruit participants and provide insights at scale for clinical trials, we help connect the dots between diagnostics and drug development.‍

Bio Highlights: Pam Gabris is Vice President of Development Strategy and Study Management for the Drug Development segment of LabCorp. She leads a global team responsible for implementing and delivering successful strategies for innovative and regulatory compliant drug development programs. Collaborating with other global and regional Scientific and Operational leaders, she shares responsibility for the overall scientific and financial performance of Early Development.

In this role, Pam is focused on growing the business through great science, global expansion/outreach, leading process and technological development within the business.  She also provides direction for appropriate global consistency and best practice identification and implementation of principles and processes to deliver scientific excellence.

Pam has more than 30 years of experience in toxicology, drug development strategy, process improvement, alliance, and program management and has led the development of processes and key metrics for global teams. She spent more than 4 years in a rotational role as the Site Lead for the Madison Labcorp campus, consisting of Early Development, Bioanalytical and Clinical Development teams.

Pam has been a member of the BioForward Board of directors since 2022.

‍